Petak I - Search Results

1

Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.

Pinter F, Papay J, Almasi A, Sapi Z, Szabo E, Kanya M, Tamasi A, Jori B, Varkondi E, Moldvay J, Szondy K, Keri G, Dominici M, Conte P, Eckhardt S, Kopper L, Schwab R, Petak I. Pinter F, et al. Among authors: petak i. J Mol Diagn. 2008 Mar;10(2):160-8. doi: 10.2353/jmoldx.2008.070125. Epub 2008 Feb 7. J Mol Diagn. 2008. PMID: 18258923 Free PMC article.

2

Modulation of apoptosis signaling in etoposide-treated lymphoma cells.

Sebestyén A, Mihalik R, Peták I, Kopper L. Sebestyén A, et al. Among authors: petak i. Anticancer Res. 1997 Jul-Aug;17(4A):2609-14. Anticancer Res. 1997. PMID: 9252689

3

Molecular genetic basis of cancer development.

Kopper L, Peták I, Sebestyén A. Kopper L, et al. Among authors: petak i. Ann N Y Acad Sci. 1997 Sep 17;824:1-7. doi: 10.1111/j.1749-6632.1997.tb46205.x. Ann N Y Acad Sci. 1997. PMID: 9382434 Review. No abstract available.

4

BCNU is a caspase-mediated inhibitor of drug-induced apoptosis.

Peták I, Mihalik R, Bauer PI, Süli-Vargha H, Sebestyén A, Kopper L. Peták I, et al. Cancer Res. 1998 Feb 15;58(4):614-8. Cancer Res. 1998. PMID: 9485009

5

Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrosobenzamide.

Mihalik R, Bauer P, Peták I, Krajcsi P, Marton A, Kun E, Kopper L. Mihalik R, et al. Among authors: petak i. Int J Cancer. 1999 Sep 9;82(6):875-9. doi: 10.1002/(sici)1097-0215(19990909)82:6<875::aid-ijc17>3.0.co;2-t. Int J Cancer. 1999. PMID: 10446456

6

TGF beta 1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells.

Tótth A, Sebestyén A, Barna G, Nagy K, Göndör A, Bocsi J, Mihalik R, Peták I, Houghton J, Kopper L. Tótth A, et al. Among authors: petak i. Anticancer Res. 2001 Mar-Apr;21(2A):1207-12. Anticancer Res. 2001. PMID: 11396165

7

Molecular pathology of tumor metastasis III. Target array and combinatorial therapies.

Tímár J, Ladányi A, Peták I, Jeney A, Kopper L. Tímár J, et al. Among authors: petak i. Pathol Oncol Res. 2003;9(1):49-72. doi: 10.1007/BF03033715. Epub 2003 Apr 18. Pathol Oncol Res. 2003. PMID: 12704448 Free article. Review.

8

Comparison of ELISA-based tyrosine kinase assays for screening EGFR inhibitors.

Varkondi E, Schäfer E, Bökönyi G, Gyökeres T, Orfi L, Petak I, Pap A, Szokoloczi O, Keri G, Schwab R. Varkondi E, et al. Among authors: petak i. J Recept Signal Transduct Res. 2005;25(1):45-56. doi: 10.1081/rrs-200055095. J Recept Signal Transduct Res. 2005. PMID: 15960394

9

Proteasome inhibitors abolish cell death downstream of caspase activation during anti-microtubule drug-induced apoptosis in leukemia cells.

Nagy K, Petak I, Imre G, Barna G, Gezane-Csorba M, Sebestyen A, Houghton JA, Mihalik R, Kopper L. Nagy K, et al. Among authors: petak i. Anticancer Res. 2005 Sep-Oct;25(5):3321-6. Anticancer Res. 2005. PMID: 16101145 Free article.

10

Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.

Schwab R, Pinter F, Moldavy J, Papay J, Strausz J, Kopper L, Keri G, Pap A, Petak I, Oreskovich K, Mangel L. Schwab R, et al. Among authors: petak i. J Clin Oncol. 2005 Oct 20;23(30):7736-8. doi: 10.1200/JCO.2005.02.4760. J Clin Oncol. 2005. PMID: 16234532 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters